Brief: Atara Biotherapeutics Inc - Gregory A. Ciongoli Appointed As Chair Of Atara Board - SEC Filing
04/09/2025 11:08
Atara Biotherapeutics Inc ATRA.O: ATARA BIOTHERAPEUTICS INC - GREGORY A. CIONGOLI APPOINTED AS CHAIR OF ATARA BOARD - SEC FILING ATARA BIOTHERAPEUTICS INC - BOARD REDUCES SIZE TO SEVEN DIRECTORS - SEC FILING Source text: [ID:n0000950170-25-112898] Further company coverage: ATRA.O
Recent news on Atara Biotherapeutics
See all newsAtara Biotherapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Atara Biotherapeutics Q2 revenue falls on deferred revenue recognition
Brief: Atara Biotherapeutics Q2 EPS USD -0.32
Atara Biotherapeutics, Inc. expected to post a loss of 31 cents a share - Earnings Preview
Brief: Atara Biotherapeutics - May Offer Up To $79.27 Million In Common Stock As Of May 12, 2026 - SEC Filing